BC1618

CAS No. 2222094-18-8

BC1618 ( 2-Propanol, 1-[bis(phenylmethyl)amino]-3-[4-(trifluoromethyl)phenoxy]- )

Catalog No. M24005 CAS No. 2222094-18-8

BC1618 is an orally active Fbxo48 inhibitory compound, stimulates Ampk-dependent signaling.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 68 In Stock
10MG 110 In Stock
25MG 222 In Stock
50MG 380 In Stock
100MG 565 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BC1618
  • Note
    Research use only, not for human use.
  • Brief Description
    BC1618 is an orally active Fbxo48 inhibitory compound, stimulates Ampk-dependent signaling.
  • Description
    BC1618 is an orally active Fbxo48 inhibitory compound, stimulates Ampk-dependent signaling. It promotes mitochondrial fission, facilitates autophagy and improves hepatic insulin sensitivity.
  • Synonyms
    2-Propanol, 1-[bis(phenylmethyl)amino]-3-[4-(trifluoromethyl)phenoxy]-
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    AMPK
  • Recptor
    AMPK;E1/E2/E3 Enzyme;Fbxo48;Mitophagy
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2222094-18-8
  • Formula Weight
    415.5
  • Molecular Formula
    C24H24F3NO2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL?(240.70 mM;?Need ultrasonic)
  • SMILES
    OC(COC1=CC=C(C(F)(F)F)C=C1)CN(CC2=CC=CC=C2)CC3=CC=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yuan Liu, et al. A Fbxo48 inhibitor prevents pAMPKα degradation and ameliorates insulin resistance. Nat Chem Biol. 2021 Mar;17(3):298-306.
molnova catalog
related products
  • Gomisin J

    Gomisin J is a natural product and have vasodilatory activity.?Gomisin J suppresses lipid accumulation by regulating the expression of lipogenic and lipolytic enzymes and inflammatory molecules through activation of AMPK, LKB1 and Ca2+/calmodulin-dependent protein kinase II and inhibition of fetuin-A in HepG2 cells.

  • 8-Chloroadenosine

    8-Chloroadenosine is a 5' AMP-activated protein kinase agonist potentially for the treatment of chronic lymphocytic leukemia.

  • ZLN-024

    A novel AMPK allosteric activator that has no effect on mitochondrial function or the ADP/ATP ratio; directly activate recombinant AMPK α1β1γ1 and its homologue α2β1γ1 with EC50 of 0.42 uM and 0.95 uM, respectively.